Pediatrix Medical Group Cash Flow Statement
MD / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 15 fiscal years. All figures from audited SEC 10-K filings.
Pediatrix Medical Group generated $271M in operating cash flow in FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 0.65 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | $165.4M | -$99.1M | -$60.4M | $66.3M | $131.0M | -$796.5M | -$1.5B | $268.6M | $320.4M | $324.9M | $336.3M | $317.3M | $280.5M | $240.9M | $218.0M |
| Depreciation & Amortization | $21.8M | $32.2M | $36.2M | $35.6M | $32.1M | $28.4M | $25.9M | $24.4M | $78.9M | $89.3M | $64.2M | $46.0M | $40.0M | $30.8M | $25.3M |
| Operating Cash Flow | $271.1M | $206.6M | $137.3M | $166.9M | $76.7M | $204.6M | $357.7M | $313.7M | $511.4M | $443.8M | $368.7M | $422.6M | $405.4M | $324.9M | $270.7M |
| Share Buybacks | $86.7M | $1.7M | $919.0K | $88.5M | $4.7M | $8.5M | $145.3M | $302.2M | $70.2M | $61.8M | $235.1M | $488.4M | $51.9M | - | - |